MLCommons and Hugging Face team up to release massive speech dataset for AI research
The nonprofit AI safety org MLCommons has teamed up with Hugging Face to release a public domain dataset of speech recordings ...
Business Wire18d
Guardant Health, ConcertAI Collaborate to Form First Data-As-A-Service That Integrates Clinical and Tumor Profiling Data to Accelerate Cancer Therapy Research and Development
The configurable real-world data (RWD) set can be used to elicit important insights into the drivers of therapy response and resistance across the treatment spectrum, and to support targeted ...
Ohio University18d
Banning TikTok: Turning point for U.S. data security or threat to free speech?
Ohio University experts in cybersecurity, international strategy, and media law weigh in on the complex issues at play, and explore the privacy and security risks, geopolitical tensions, free speech ...
martech21d
Free speech, Meta, data privacy and email: A delicate balance or a complete disconnect?
Meta’s recent decision to move from fact-checkers to a community notes model akin to X, highlights a growing divide in how digital platforms handle free speech and content ... requires explicit ...
Seeking Alpha23d
Crinetics falls after mid-stage trial data adrenal disorder therapy
Shares of Crinetics Pharmaceuticals (NASDAQ:CRNX) traded sharply lower after the company posted initial data from a Phase 2 trial for atumelnant, its experimental therapy for congenital adrenal ...
The Daily Telegraph24d
EU fines itself after accidentally breaching its own data rules
The European Union has been fined for breaking its own data protection laws after a court forced it to pay €400 (£335) to a German citizen for transferring his data to the US. The EU General ...
ENDPOINTS NEWS25d
Sana’s stock soars on new cell ther­a­py da­ta; UniQure’s $75M of­fer­ing
Plus, news about Bioin­vent, Al­pha Cog­ni­tion, Neu­mir­na Ther­a­peu­tics and Cas­sa­va Sci­ences: Sana Biotech­nol­o­gy finds life with new type 1 di­a­betes cell ther­a­py ...
FierceBiotech26d
Sana’s cell therapy may be ‘transformative cure’ for type 1 diabetes: analysts
Sana Biotechnology has shared early data for its investigational allogeneic cell therapy being studied in one patient with type 1 diabetes, sending the company’s share price up by about 200%.
vic28d
Training data collection
If this is the first time you have submitted data in the collection, you will need to contact us to obtain valid login details. In an email, provide your name, telephone number and training ...